A Phytopharmacological Review of Prospective of Bhrungaraj (Eclipta alba Hassk.)
DOI:
https://doi.org/10.47552/ijam.v8i1.892Keywords:
Bhrungaraj, Eclipta alba, Eclipta erecta, Eclipta prostate, HepatoprotectiveAbstract
Eclipta alba Hassk.(compositeae) is an important small branched annual herbaceous plant in Ayurveda  described first by Bhavprakasha and is widely used for treating various ailments in the Indian system of medicine. Aim: Aim of this review is to provide comprehensive information on the pharmacological activities of various part of Eclipta alba Hassk. Setting and design: This is a contribution which provides a comprehensive review on ethnomedicinal uses, chemical composition, and the pharmacological profile of Eclipta alba Hassk. as an important medicinal plant. Material and methods: All the relevant universally accepted electronic databases were searched with respect to the terms “Bhrungarajâ€, “False Daisyâ€, “Eclipta erecta,â€, “Eclipta prostate,â€, “Verbesina alba, â€& Verbesina prostrate†including Indian classical texts, pharmacopoeias, Ayurvedic books, journals, etc., for information without specific timeline. Complete information of the plant has been collected manually. Result and conclusion: The collected data reflects that many ethno‑medicinal claims have been confirmed through the modern in‑vitro and in vivo pharmacological studies using different extracts and their isolates of Eclipta alba Hassk. The isolation of active constituents, their biological actions, clinical safety and validation of traditional uses of Eclipta alba could provide leads for further scientific research. The information collected here will be useful to set‑up research protocols for modern drugs and Ayurvedic formulation development.
Â
Downloads
Published
How to Cite
Issue
Section
License
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.